+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Next-generation Sequencing Services Market Size, Share & Trends Analysis Report by Service Type (Human Genome Sequencing, Gene Regulation Services), Workflow, End Use and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 4700908
The global next-generation sequencing services market size was estimated at USD 6.66 billion in 2024 and is anticipated to reach USD 40.43 billion by 2033, expanding at a CAGR of 22.54% from 2025 to 2033. This growth is driven by the increasing demand for advanced genomic research, the rising prevalence of genetic disorders, and the growing adoption of precision medicine.

Increased Prevalence of Genetic and Chronic Diseases

One of the most significant drivers fueling demand in the next-generation sequencing (NGS) services industry is the rising global burden of genetic and chronic diseases. Conditions such as cancer, cardiovascular diseases, neurological disorders, and rare inherited syndromes are increasing in prevalence, prompting a heightened need for advanced diagnostic tools. Traditional diagnostic methods often fail to identify the underlying genetic causes of complex diseases, whereas NGS offers comprehensive genomic insights that enable early detection and precise diagnosis. For instance, according to data from the Centers for Disease Control and Prevention (CDC), 6 out of 10 Americans suffer from at least one chronic illness. At the same time, 4 out of 10 are affected by two or more chronic conditions. As healthcare systems worldwide shift toward preventive and precision medicine, the demand for robust, accurate, and scalable sequencing services continues to surge.

Rare genetic disorders, often undiagnosed due to their complexity and rarity, can now be effectively identified through whole-genome and exome sequencing provided by NGS services. For example, NGS can detect somatic mutations in cancer patients, facilitating the development of personalized treatment plans and improving patient outcomes. Moreover, as more individuals seek comprehensive genetic information to understand disease risks and inform their healthcare decisions, clinical laboratories, hospitals, and research institutions are increasingly becoming specialized NGS service providers. This trend is expected to intensify during the forecast period, positioning NGS services as an indispensable tool in the global fight against chronic and hereditary diseases.

Global Next-Generation Sequencing Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the next-generation sequencing services market on the basis of service type, workflow, end use, and region:

Service Type Outlook (Revenue, USD Million, 2021-2033)

  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-based Sequencing Services
  • Gene Regulation Services
  • Animal & Plant Sequencing Services
  • Other Sequencing Services

Workflow Outlook (Revenue, USD Million, 2021-2033)

  • Pre-sequencing
  • Sequencing
  • Data Analysis

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Universities & Other Research Entities
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Information Procurement
1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
1.7.1. Objective 1
1.7.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Derivers
3.3.1. Increased Prevalence of Genetic and Chronic Diseases
3.3.2. Rising emphasis on quality control and safety
3.4. Market Restraint Analysis
3.4.1. Challenges pertaining to the implementation of large-scale NGS analysis workflows
3.4.2. Analytical challenges in single-cell sequencing
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
Chapter 4. Service Type Business Analysis
4.1. Global Next-Generation Sequencing Services Market: Service Type Movement Analysis
4.2. Human Genome Sequencing Services
4.2.1. Human Genome Sequencing Services Market, 2021-2033 (USD Million)
4.3. Single-Cell Sequencing Services
4.3.1. Single-Cell Sequencing Services Market, 2021-2033 (USD Million)
4.4. Microbial Genome-based Sequencing Services
4.4.1. Microbial Genome-based Sequencing Services Market, 2021-2033 (USD Million)
4.5. Gene Regulation Services
4.5.1. Gene Regulation Services Market, 2021-2033 (USD Million)
4.5.2. Small RNA Sequencing Services
4.5.2.1. Small RNA Sequencing Services Market, 2021-2033 (USD Million)
4.5.3. Chip Sequencing Services
4.5.3.1. Chip Sequencing Services Market, 2021-2033 (USD Million)
4.5.4. Other Gene Regulation-based Service
4.5.4.1. Other Gene Regulation-based Service Market, 2021-2033 (USD Million)
4.6. Animal & Plant Sequencing Services
4.6.1. Animal & Plant Sequencing Services Market, 2021-2033 (USD Million)
4.7. Other Sequencing Services
4.7.1. Other Sequencing Services Market, 2021-2033 (USD Million)
Chapter 5. Workflow Business Analysis
5.1. Global Next-Generation Sequencing Services Market: Workflow Movement Analysis
5.2. Pre Sequencing Service
5.2.1. Pre Sequencing Service Market, 2021-2033 (USD Million)
5.3. Sequencing Service
5.3.1. Sequencing Service Market, 2021-2033 (USD Million)
5.4. Data Analysis Service
5.4.1. Data Analysis Service Market, 2021-2033 (USD Million)
Chapter 6. End Use Business Analysis
6.1. Global Next-Generation Sequencing Services Market: End Use Movement Analysis
6.2. Universities & Other Research Entities
6.2.1. Universities & Other Research Entities Market, 2021-2033 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Hospitals & Clinics Market, 2021-2033 (USD Million)
6.4. Pharma & Biotech Entities
6.4.1. Pharma & Biotech Entities Market, 2021-2033 (USD Million)
6.5. Others
6.5.1. Others Market, 2021-2033 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Global Next-Generation Sequencing Services Market Share, By Region, 2024 & 2033
7.2. North America
7.2.1. North America Next-generation sequencing services market, 2021-2033 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. Next-generation sequencing services market, 2021-2033 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada Next-generation sequencing services market, 2021-2033 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Competitive Scenario
7.2.4.3. Regulatory Framework
7.2.4.4. Target Disease Prevalence
7.2.4.5. Mexico Next-generation sequencing services market, 2021-2033 (USD Million)
7.3. Europe
7.3.1. Europe Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. Germany Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. UK Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. France Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. Italy Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Spain Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway Next-generation sequencing services market, 2021-2033 (USD Million)
7.3.10. Switzerland
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Regulatory Framework
7.3.10.4. Target Disease Prevalence
7.3.10.5. Switzerland Next-generation sequencing services market, 2021-2033 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific Next-generation sequencing services market, 2021-2033 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan Next-generation sequencing services market, 2021-2033 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China Next-generation sequencing services market, 2021-2033 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India Next-generation sequencing services market, 2021-2033 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea Next-generation sequencing services market, 2021-2033 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Australia Next-generation sequencing services market, 2021-2033 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Thailand Next-generation sequencing services market, 2021-2033 (USD Million)
7.4.8. Singapore
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Target Disease Prevalence
7.4.8.5. Singapore Next-generation sequencing services market, 2021-2033 (USD Million)
7.5. Latin America
7.5.1. Latin America Next-generation sequencing services market, 2021-2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil Next-generation sequencing services market, 2021-2033 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Argentina Next-generation sequencing services market, 2021-2033 (USD Million)
7.6. MEA
7.6.1. MEA Next-generation sequencing services market, 2021-2033 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa Next-generation sequencing services market, 2021-2033 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia Next-generation sequencing services market, 2021-2033 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE Next-generation sequencing services market, 2021-2033 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait Next-generation sequencing services market, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market/Position Share Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Illumina, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Thermo Fisher Scientific Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. BGI Genomics
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Eurofins Genomics
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. GENEWIZ
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Macrogen Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. QIAGEN N.V.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Agilent Technologies Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Revvity, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Twist Bioscience
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global next-generation sequencing services market by service type, 2021-2033 (USD million)
Table 4 Global next-generation sequencing services market by workflow, 2021-2033 (USD million)
Table 5 Global next-generation sequencing services market by end use, 2021-2033 (USD million)
Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 8 North America next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2021-2033 (USD Million)
Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 15 Canada next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 16 Mexico next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 17 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 18 Mexico next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 19 Europe next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 20 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 21 Europe next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 22 Europe next-generation sequencing services market estimates & forecasts, by country, 2021-2033 (USD Million)
Table 23 Germany next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 24 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 25 Germany next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 26 UK next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 27 UK next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 28 UK next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 29 France next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 30 France next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 31 France next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 32 Italy next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 33 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 34 Italy next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 35 Spain next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 36 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 37 Spain next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 38 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 39 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 40 Denmark next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 41 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 42 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 43 Sweden next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 44 Norway next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 45 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 46 Norway next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 47 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 48 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 49 Switzerland next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 50 Asia-Pacific next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 51 Asia-Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 52 Asia-Pacific next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 53 Asia-Pacific next-generation sequencing services market estimates & forecasts, by country, 2021-2033 (USD Million)
Table 54 Japan next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 55 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 56 Japan next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 57 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 58 China next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 59 China next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 60 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 61 India next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 62 India next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 63 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 64 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 65 Australia next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 66 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 67 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 68 South Korea next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 69 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 70 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 71 Thailand next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 72 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 73 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 74 Singapore next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 75 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 76 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 77 Latin America next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 78 Latin America next-generation sequencing services market estimates & forecasts, by country, 2021-2033 (USD Million)
Table 79 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 80 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 81 Brazil next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 87 MEA next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2021-2033 (USD Million)
Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 97 UAE next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2021-2033 (USD Million)
Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2021-2033 (USD Million)
Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end use, 2021-2033 (USD Million)
Table 101 Participant’s Overview
List of Figures
Figure 1 Market Others process
Figure 2 Data triangulation techniques
Figure 3 Primary Others pattern
Figure 4 Market Others approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Market summary, 2024 (USD Million)
Figure 9 Market segmentation & scope
Figure 10 Market driver impact
Figure 11 Market restraint impact
Figure 12 Penetration & growth prospect mapping
Figure 13 Porter’s analysis
Figure 14 SWOT analysis
Figure 15 Next-generation sequencing services market: Service type outlook and key takeaways
Figure 16 Next-generation sequencing services market: Service type movement analysis
Figure 17 Human genome sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 18 Single-cell sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 19 Microbial genome-based sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 20 Gene regulation services market estimates and forecast, 2021-2033 (USD Million)
Figure 21 Small RNA sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 22 Chip sequencing service market estimates and forecast, 2021-2033 (USD Million)
Figure 23 Other gene regulation-based service market estimates and forecast, 2021-2033 (USD Million)
Figure 24 Animal & plant sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 25 Other sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 26 Next-generation sequencing services market: Workflow outlook and key takeaways
Figure 27 Next-generation sequencing services market: Workflow movement analysis
Figure 28 Pre-sequenceing services market estimates and forecast, 2021-2033 (USD Million)
Figure 29 Sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 30 Data analysis service market estimates and forecast, 2021-2033 (USD Million)
Figure 31 Next-generation sequencing services market: End use outlook and key takeaways
Figure 32 Next-generation sequencing services market: End use movement analysis
Figure 33 Universities & other research entities, 2021-2033 (USD Million)
Figure 34 Hospitals & clinics, 2021-2033 (USD Million)
Figure 35 Pharma & biotech entities, 2021-2033 (USD Million)
Figure 36 Other end use, 2021-2033 (USD Million)
Figure 37 Global next-generation sequencing services market: Regional outlook and key takeaways
Figure 38 North America next-generation sequencing services market, 2021-2033 (USD Million)
Figure 39 U.S. key country dynamics
Figure 40 U.S. next-generation sequencing services market, 2021-2033 (USD Million)
Figure 41 Canada key country dynamics
Figure 42 Canada next-generation sequencing services market, 2021-2033 (USD Million)
Figure 43 Mexico key country dynamics
Figure 44 Mexico next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 45 Europe next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 46 Germany key country dynamics
Figure 47 Germany next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 48 France key country dynamics
Figure 49 France next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 50 UK key country dynamics
Figure 51 UK next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 52 Italy key country dynamics
Figure 53 Italy next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 54 Spain key country dynamics
Figure 55 Spain next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 56 Denmark key country dynamics
Figure 57 Denmark next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 58 Sweden key country dynamics
Figure 59 Sweden next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Norway key country dynamics
Figure 61 Norway next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 62 Switzerland key country dynamics
Figure 63 Switzerland next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 64 Asia-Pacific next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 65 China key country dynamics
Figure 66 China next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 67 India key country dynamics
Figure 68 India next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 69 South Korea key country dynamics
Figure 70 South Korea next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 71 Japan key country dynamics
Figure 72 Japan next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 73 Australia key country dynamics
Figure 74 Australia next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 75 Thailand key country dynamics
Figure 76 Thailand next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 77 Singapore key country dynamics
Figure 78 Singapore next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 79 Latin America next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 80 Brazil key country dynamics
Figure 81 Brazil next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 82 Argentina key country dynamics
Figure 83 Argentina next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 84 MEA next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 85 South Africa key country dynamics
Figure 86 South Africa next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 87 Saudi Arabia key country dynamics
Figure 88 Saudi Arabia next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 89 UAE key country dynamics
Figure 90 UAE next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)
Figure 91 Kuwait key country dynamics
Figure 92 Kuwait next-generation sequencing services market estimates and forecast, 2021-2033 (USD Million)

Companies Mentioned

The key companies profiled in this Next-generation Sequencing Services market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • BGI Genomics
  • Eurofins Genomics
  • GENEWIZ
  • Macrogen Inc.
  • QIAGEN N.V.
  • Agilent Technologies Inc.
  • Revvity, Inc.
  • Twist Bioscience

Table Information